Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

IPXLE

Impax labs (IPXLE)

Impax Laboratories (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IPXLE
DateTimeSourceHeadlineSymbolCompany
20/01/201708:27Dow Jones NewsRival to EpiPen Allergy Treatment to Return to Market--UpdateNASDAQ:IPXLEImpax Laboratories (MM)
20/01/201707:17Dow Jones NewsRival to EpiPen Allergy Treatment to Return to MarketNASDAQ:IPXLEImpax Laboratories (MM)
13/01/201709:03Dow Jones NewsCigna Drops Coverage of Mylan's EpiPen for Cheaper Generic -- UpdateNASDAQ:IPXLEImpax Laboratories (MM)
04/11/201607:08Dow Jones NewsDOJ Looking Into Possible Price Collusion in Generic Drug Sector -BloombergNASDAQ:IPXLEImpax Laboratories (MM)
28/07/201609:41Dow Jones NewsCorrection to Teva, Allergan ArticleNASDAQ:IPXLEImpax Laboratories (MM)
28/07/201606:00Dow Jones NewsTeva, Allergan Get FTC Approval for Generics PurchaseNASDAQ:IPXLEImpax Laboratories (MM)
28/07/201605:51Dow Jones NewsTeva, Allergan Get FTC Approval for Generics PurchaseNASDAQ:IPXLEImpax Laboratories (MM)
13/07/201609:20Dow Jones NewsTeva Raises GuidanceNASDAQ:IPXLEImpax Laboratories (MM)
22/06/201617:07Dow Jones NewsBusiness Watch -- WSJNASDAQ:IPXLEImpax Laboratories (MM)
21/06/201623:30Dow Jones NewsTeva and Allergan Sell Generic Drugs to Impax In Latest DivestitureNASDAQ:IPXLEImpax Laboratories (MM)
21/06/201623:17Dow Jones NewsTeva and Allergan Sell Generic Drugs to Impax In Latest DivestitureNASDAQ:IPXLEImpax Laboratories (MM)
01/04/201602:50Dow Jones NewsFTC Accuses Endo of Paying Off Generic DrugmakersNASDAQ:IPXLEImpax Laboratories (MM)
23/09/201513:50Dow Jones NewsTuring to Cut Price of Drug Daraprim After OutcryNASDAQ:IPXLEImpax Laboratories (MM)
05/08/200518:00Business WireIMPAX Receives Notice of Delisting from NasdaqNASDAQ:IPXLEImpax Laboratories (MM)
05/08/200518:00Business WireIMPAX Receives Notice of Delisting from NasdaqNASDAQ:IPXLEImpax Laboratories (MM)
03/08/200518:00Business WireIMPAX Provides Further Update of Progress in Filing 10-K and 10-Q and Estimates of ResultsNASDAQ:IPXLEImpax Laboratories (MM)
03/08/200518:00Business WireIMPAX Provides Further Update of Progress in Filing 10-K and 10-Q and Estimates of ResultsNASDAQ:IPXLEImpax Laboratories (MM)
27/06/200521:00Business WireIMPAX Laboratories, Inc. Agrees to Sell $75 Million of 3.5% Senior Subordinated Convertible Debentures Due 2012; Proceeds to beNASDAQ:IPXLEImpax Laboratories (MM)
20/06/200522:01Business WireIMPAX to Increase Existing Credit FacilityNASDAQ:IPXLEImpax Laboratories (MM)
04/05/200523:03Business WireIMPAX Provides Updates on Progress to File 10-K and Related MattersNASDAQ:IPXLEImpax Laboratories (MM)
04/05/200523:03Business WireIMPAX Provides Updates on Progress to File 10-K and Related MattersNASDAQ:IPXLEImpax Laboratories (MM)
03/05/200501:01Business WireCORRECTING and REPLACING IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 20NASDAQ:IPXLEImpax Laboratories (MM)
02/05/200523:24Business WireIMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 2005NASDAQ:IPXLEImpax Laboratories (MM)
 Showing the most relevant articles for your search:NASDAQ:IPXLE